pharmaseal international limited
pharmaseal international limited Company Information
Company Number
09993255
Next Accounts
Dec 2025
Shareholders
daljit cheema
seedrs nominees limited
View AllGroup Structure
View All
Industry
Computer consultancy activities
Registered Address
ingenuity centre, nottingham university innovation, nottingham, nottinghamshire, NG7 2TU
Website
www.pharmaseal.copharmaseal international limited Estimated Valuation
Pomanda estimates the enterprise value of PHARMASEAL INTERNATIONAL LIMITED at £439.2k based on a Turnover of £667.5k and 0.66x industry multiple (adjusted for size and gross margin).
pharmaseal international limited Estimated Valuation
Pomanda estimates the enterprise value of PHARMASEAL INTERNATIONAL LIMITED at £0 based on an EBITDA of £-191.2k and a 4.64x industry multiple (adjusted for size and gross margin).
pharmaseal international limited Estimated Valuation
Pomanda estimates the enterprise value of PHARMASEAL INTERNATIONAL LIMITED at £524.8k based on Net Assets of £229.6k and 2.29x industry multiple (adjusted for liquidity).
Edit your figures and get a professional valuation report.
Pharmaseal International Limited Overview
Pharmaseal International Limited is a live company located in nottingham, NG7 2TU with a Companies House number of 09993255. It operates in the information technology consultancy activities sector, SIC Code 62020. Founded in February 2016, it's largest shareholder is daljit cheema with a 31.8% stake. Pharmaseal International Limited is a young, small sized company, Pomanda has estimated its turnover at £667.5k with healthy growth in recent years.
Upgrade for unlimited company reports & a free credit check
Pharmaseal International Limited Health Check
Pomanda's financial health check has awarded Pharmaseal International Limited a 3 rating. We use a traffic light system to show it exceeds the industry average on 3 measures and has 5 areas for improvement. Company Health Check FAQs
3 Strong
3 Regular
5 Weak
Size
annual sales of £667.5k, make it smaller than the average company (£1.3m)
- Pharmaseal International Limited
£1.3m - Industry AVG
Growth
3 year (CAGR) sales growth of 10%, show it is growing at a similar rate (9.3%)
- Pharmaseal International Limited
9.3% - Industry AVG
Production
with a gross margin of 44.1%, this company has a comparable cost of product (44.1%)
- Pharmaseal International Limited
44.1% - Industry AVG
Profitability
an operating margin of -28.9% make it less profitable than the average company (6.1%)
- Pharmaseal International Limited
6.1% - Industry AVG
Employees
with 8 employees, this is below the industry average (12)
8 - Pharmaseal International Limited
12 - Industry AVG
Pay Structure
on an average salary of £59.1k, the company has an equivalent pay structure (£59.1k)
- Pharmaseal International Limited
£59.1k - Industry AVG
Efficiency
resulting in sales per employee of £83.4k, this is less efficient (£130.1k)
- Pharmaseal International Limited
£130.1k - Industry AVG
Debtor Days
it gets paid by customers after 37 days, this is earlier than average (62 days)
- Pharmaseal International Limited
62 days - Industry AVG
Creditor Days
its suppliers are paid after 109 days, this is slower than average (28 days)
- Pharmaseal International Limited
28 days - Industry AVG
Stock Days
There is insufficient data available for this Key Performance Indicator!
- Pharmaseal International Limited
- - Industry AVG
Cash Balance
has cash to cover current liabilities for 59 weeks, this is more cash available to meet short term requirements (17 weeks)
59 weeks - Pharmaseal International Limited
17 weeks - Industry AVG
Debt Level
it has a ratio of liabilities to total assets of 65.3%, this is a higher level of debt than the average (55.5%)
65.3% - Pharmaseal International Limited
55.5% - Industry AVG
PHARMASEAL INTERNATIONAL LIMITED financials
Pharmaseal International Limited's latest turnover from March 2024 is estimated at £667.5 thousand and the company has net assets of £229.6 thousand. According to their latest financial statements, Pharmaseal International Limited has 8 employees and maintains cash reserves of £463.6 thousand as reported in the balance sheet.
Data source: Companies House, Pomanda Estimates
| Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Mar 2019 | Mar 2018 | Mar 2017 | |
|---|---|---|---|---|---|---|---|---|
| Turnover | ||||||||
| Other Income Or Grants | ||||||||
| Cost Of Sales | ||||||||
| Gross Profit | ||||||||
| Admin Expenses | ||||||||
| Operating Profit | ||||||||
| Interest Payable | ||||||||
| Interest Receivable | ||||||||
| Pre-Tax Profit | ||||||||
| Tax | ||||||||
| Profit After Tax | ||||||||
| Dividends Paid | ||||||||
| Retained Profit | ||||||||
| Employee Costs | ||||||||
| Number Of Employees | 8 | 7 | 8 | 9 | 10 | 6 | 5 | 1 |
| EBITDA* |
* Earnings Before Interest, Tax, Depreciation and Amortisation
| Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Mar 2019 | Mar 2018 | Mar 2017 | |
|---|---|---|---|---|---|---|---|---|
| Tangible Assets | 3,305 | 3,377 | 3,016 | 3,517 | 4,661 | 4,097 | 1,652 | |
| Intangible Assets | ||||||||
| Investments & Other | ||||||||
| Debtors (Due After 1 year) | ||||||||
| Total Fixed Assets | 3,305 | 3,377 | 3,016 | 3,517 | 4,661 | 4,097 | 1,652 | |
| Stock & work in progress | ||||||||
| Trade Debtors | 68,941 | 1,465 | 54,068 | 5,786 | ||||
| Group Debtors | ||||||||
| Misc Debtors | 14,298 | 314,450 | 188,726 | 37,625 | 205,059 | 117,192 | 45,479 | 6,537 |
| Cash | 463,584 | 260,470 | 254,449 | 478,506 | 51,581 | 888,268 | 361,707 | 70,216 |
| misc current assets | 110,891 | |||||||
| total current assets | 657,714 | 576,385 | 443,175 | 570,199 | 256,640 | 1,011,246 | 407,186 | 76,753 |
| total assets | 661,019 | 579,762 | 446,191 | 573,716 | 261,301 | 1,015,343 | 408,838 | 76,753 |
| Bank overdraft | 5,000 | 5,000 | 10,000 | 3,333 | ||||
| Bank loan | ||||||||
| Trade Creditors | 112,261 | 125,096 | 95,472 | 41,445 | 50,465 | 32,468 | 13,734 | 12,941 |
| Group/Directors Accounts | 141,999 | 141,999 | 141,999 | 137,000 | ||||
| other short term finances | ||||||||
| hp & lease commitments | ||||||||
| other current liabilities | 287,154 | 545,456 | 300,826 | 162,408 | 51,758 | 16,368 | 3,383 | 7,630 |
| total current liabilities | 404,415 | 675,552 | 406,298 | 207,186 | 244,222 | 190,835 | 159,116 | 157,571 |
| loans | 27,018 | 31,624 | 33,667 | 46,667 | ||||
| hp & lease commitments | ||||||||
| Accruals and Deferred Income | ||||||||
| other liabilities | ||||||||
| provisions | ||||||||
| total long term liabilities | 27,018 | 31,624 | 33,667 | 46,667 | ||||
| total liabilities | 431,433 | 707,176 | 439,965 | 253,853 | 244,222 | 190,835 | 159,116 | 157,571 |
| net assets | 229,586 | -127,414 | 6,226 | 319,863 | 17,079 | 824,508 | 249,722 | -80,818 |
| total shareholders funds | 229,586 | -127,414 | 6,226 | 319,863 | 17,079 | 824,508 | 249,722 | -80,818 |
| Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Mar 2019 | Mar 2018 | Mar 2017 | |
|---|---|---|---|---|---|---|---|---|
| Operating Activities | ||||||||
| Operating Profit | ||||||||
| Depreciation | 1,652 | 1,688 | 1,587 | 1,757 | 2,330 | 2,048 | 826 | |
| Amortisation | ||||||||
| Tax | ||||||||
| Stock | ||||||||
| Debtors | -232,676 | 127,189 | 97,033 | -113,366 | 82,081 | 77,499 | 38,942 | 6,537 |
| Creditors | -12,835 | 29,624 | 54,027 | -9,020 | 17,997 | 18,734 | 793 | 12,941 |
| Accruals and Deferred Income | -258,302 | 244,630 | 138,418 | 110,650 | 35,390 | 12,985 | -4,247 | 7,630 |
| Deferred Taxes & Provisions | ||||||||
| Cash flow from operations | ||||||||
| Investing Activities | ||||||||
| capital expenditure | ||||||||
| Change in Investments | ||||||||
| cash flow from investments | ||||||||
| Financing Activities | ||||||||
| Bank loans | ||||||||
| Group/Directors Accounts | -141,999 | 4,999 | 137,000 | |||||
| Other Short Term Loans | ||||||||
| Long term loans | -4,606 | -2,043 | -13,000 | 46,667 | ||||
| Hire Purchase and Lease Commitments | ||||||||
| other long term liabilities | ||||||||
| share issue | ||||||||
| interest | ||||||||
| cash flow from financing | ||||||||
| cash and cash equivalents | ||||||||
| cash | 203,114 | 6,021 | -224,057 | 426,925 | -836,687 | 526,561 | 291,491 | 70,216 |
| overdraft | -5,000 | 6,667 | 3,333 | |||||
| change in cash | 203,114 | 11,021 | -230,724 | 423,592 | -836,687 | 526,561 | 291,491 | 70,216 |
pharmaseal international limited Credit Report and Business Information
Pharmaseal International Limited Competitor Analysis
Perform a competitor analysis for pharmaseal international limited by selecting its closest rivals, whether from the INFORMATION AND COMMUNICATION sector, other small companies, companies in NG7 area or any other competitors across 12 key performance metrics.
pharmaseal international limited Ownership
PHARMASEAL INTERNATIONAL LIMITED group structure
Pharmaseal International Limited has no subsidiary companies.
Ultimate parent company
PHARMASEAL INTERNATIONAL LIMITED
09993255
pharmaseal international limited directors
Pharmaseal International Limited currently has 3 directors. The longest serving directors include Mr Daljit Cheema (Feb 2016) and Mr Maqbool Ahmed (Jul 2020).
| officer | country | age | start | end | role |
|---|---|---|---|---|---|
| Mr Daljit Cheema | England | 62 years | Feb 2016 | - | Director |
| Mr Maqbool Ahmed | United Kingdom | 65 years | Jul 2020 | - | Director |
| Mr Gareth Dunn | 53 years | Jul 2020 | - | Director |
P&L
March 2024turnover
667.5k
+65%
operating profit
-192.8k
0%
gross margin
44.2%
-7.01%
turnover
Turnover, or revenue, is the amount of sales generated by a company within the financial year.
Balance Sheet
March 2024net assets
229.6k
-2.8%
total assets
661k
+0.14%
cash
463.6k
+0.78%
net assets
Total assets minus all liabilities
Similar Companies
pharmaseal international limited company details
company number
09993255
Type
Private limited with Share Capital
industry
62020 - Computer consultancy activities
incorporation date
February 2016
age
9
incorporated
UK
ultimate parent company
accounts
Total Exemption Full
last accounts submitted
March 2024
previous names
dci consulting ltd (October 2016)
accountant
M AHMED & CO
auditor
-
address
ingenuity centre, nottingham university innovation, nottingham, nottinghamshire, NG7 2TU
Bank
-
Legal Advisor
-
pharmaseal international limited Charges & Mortgages
A charge, or mortgage, refers to the rights a company gives to a lender in return for a loan, often in the form of security given over business assets.
We did not find charges/mortgages relating to pharmaseal international limited.
pharmaseal international limited Capital Raised & Share Issues BETA
When a company issues new shares, e.g. to new investors following a funding round, it is required to notify Companies House within one month of making an allotment of shares.
Click to start generating capital raising & share issue transactions for PHARMASEAL INTERNATIONAL LIMITED. This can take several minutes, an email will notify you when this has completed.
pharmaseal international limited Companies House Filings - See Documents
| date | description | view/download |
|---|
